About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Seattle | 212 Studies

Clinical Trials Colorectal CancerSeattle

Colorectal Cancer Clinical Trials in Seattle

Find 212 clinical trials for colorectal cancer near Seattle, Washington. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Seattle

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 212 trials

Active not recruitingA Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid TumorThe primary objective of this study is to assess the safety and tolerability and to determine the recommended Phase 2 dose (RP2D) of E7386 in combination with other anticancer…NCT04008797·Little Rock, Arkansas and 105 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedS0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal CancerRATIONALE: Drugs used in chemotherapy, such as oxaliplatin and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping…NCT00686166·Mobile, Alabama and 129 others

SuspendedReal-Time Feedback (RTFB) to Improve ColonoscopyTo test whether real-time feedback will improve quality of endoscopic examination.NCT05241210·Baltimore, Maryland and 2 others

RecruitingA Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)Researchers are looking for other ways to treat locally advanced or metastatic colorectal cancer (mCRC) that is unresectable and has a gene mutation called KRAS G12C.NCT06997497·Phoenix, Arizona and 237 others

UnknownA Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or CholangiocarcinomaThis study is being done to answer the following question: Is the combination of the Medtronic pump and the Codman catheter device a safe alternative to the C3000 Codman pump for…NCT04668976·Seattle, Washington

RecruitingSolid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell ManufacturingObjective: To collect information on how often a solid tumor cancer might lose the Human Leukocyte Antigen (HLA) by next generation sequencing and perform apheresis to collect…NCT04981119·Gilbert, Arizona and 15 others

TerminatedA Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary CancerThis study is to define the safety profile and to determine the Maximal tolerated dose regimen and preliminary efficacy of AbGn-107 administered every 14 days (Q2W regimen) or 28…NCT02908451·Phoenix, Arizona and 8 others

UnknownCardiac Safety Assessment Study of Picoplatin in Solid TumorsThe purpose of this study is to investigate what effects, if any, picoplatin has on the heart rhythm.NCT00710697·Scottsdale, Arizona and 6 others

RecruitingA Study of IBI363 in Subjects with Advanced Solid MalignanciesThis is a Phase 2, open-label, multicenter study designed to evaluate the efficacy, safety and tolerability of IBI363 (study drug) in subjects with advanced, refractory solid…NCT06281678·San Francisco, California and 8 others

CompletedFluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00016198·Tucson, Arizona and 73 others

TerminatedSafety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients With Limited Residual Disease After SurgeryThe purpose of this trial is to determine the safety of 90Y-hMN14 at different dose levels in the treatment of residual colorectal cancer following recent surgery.NCT00041691·Washington D.C., District of Columbia and 1 other

CompletedStudy of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With ColorecThe purpose of this study is to determine whether treatment with Selumetinib (AZD6244) (Hyd-Sulfate) in combination with Irinotecan as a second treatment in patients with K-ras or…NCT01116271·Los Angeles, California and 11 others

Active not recruitingA Study of PARG Inhibitor IDE161 in Participants With Advanced Solid TumorsThe purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.NCT05787587·Phoenix, Arizona and 26 others

WithdrawnProspective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood SamplesThe study is intended to collect specimens to support the application of genome analysis technologies, including large-scale genome sequencing.NCT01792882·Seattle, Washington

CompletedA Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic TumorsThis is a Phase 1a/1b, open-label, multicenter, global, dose-escalation study designed to evaluate the safety, tolerability, immune response, and pharmacokinetics of autogene…NCT03289962·Scottsdale, Arizona and 32 others

RecruitingThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)The Phase 2 monotherapy portion of this study is currently enrolling and will evaluate the efficacy and safety of PC14586 (INN rezatapopt) in participants with locally advanced or…NCT04585750·Irvine, California and 76 others

UnknownComparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00008281·Huntsville, Alabama and 133 others

CompletedA Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.The purpose of this study is to assess the antitumor activity of ALIMTA plus Oxaliplatin combination therapy in patients with previously untreated advanced colorectal cancerNCT00034619·Huntsville, Alabama and 21 others

CompletedOxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With SurgeryPURPOSE: This randomized phase III trial is studying giving oxaliplatin, leucovorin calcium, and fluorouracil together to compare how well they work when given together with or…NCT01150045·Mobile, Alabama and 841 others

TerminatedEvaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer SurvivorsThis trial evaluates the effects a moderate-to-vigorous exercise intervention has on the bacterial make-up of the gastrointestinal tract (gut microbiota) in survivors of stage…NCT05930496·Seattle, Washington

PreviousPage 7 of 11Next

Other Conditions in Seattle

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma